Antibodies which bind factor VIII

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8784816
APP PUB NO 20130136750A1
SERIAL NO

13658365

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention, in general, features a method of treatment and/or prevention of a thrombotic pathological condition, in a mammal, which includes administering to the mammal in need of such treatment a therapeutically effective amount of a composition including an antibody directed against the C1 domain of Factor VIII, which is a partially inhibitory antibody of Factor VIII.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
LIFE SCIENCES RESEARCH PARTNERS VZW3000 LEUVEN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Jacquemin, Marc G Sart-Bernard, BE 8 67
Saint-Remy, Jean-Marie R Grez-Doiceau, BE 7 51

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 22, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00